Good to see the are still looking at pbt2 for further development.
Also for pbt434:
Benign safety profile in GLP toxicology studies
• Non‐toxic dose exceeds efficacious dose by >10‐fold based on
allometric scaling
Ann: Investor presentation - Biotech Showcase, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.14M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 45 | 14362918 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 6758592 | 6 |
View Market Depth
| Last trade - 09.45am 03/07/2025 (20 minute delay) ? |
| ATH (ASX) Chart |
Day chart unavailable